AU2003244452A1 - Method of promoting neuronal growth - Google Patents
Method of promoting neuronal growthInfo
- Publication number
- AU2003244452A1 AU2003244452A1 AU2003244452A AU2003244452A AU2003244452A1 AU 2003244452 A1 AU2003244452 A1 AU 2003244452A1 AU 2003244452 A AU2003244452 A AU 2003244452A AU 2003244452 A AU2003244452 A AU 2003244452A AU 2003244452 A1 AU2003244452 A1 AU 2003244452A1
- Authority
- AU
- Australia
- Prior art keywords
- neuronal growth
- promoting neuronal
- promoting
- growth
- neuronal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000007514 neuronal growth Effects 0.000 title 1
- 230000001737 promoting effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0202680.5 | 2002-02-05 | ||
| GB0202680A GB0202680D0 (en) | 2002-02-05 | 2002-02-05 | Novel method |
| GB0222616A GB0222616D0 (en) | 2002-09-30 | 2002-09-30 | Novel method |
| GB0222616.5 | 2002-09-30 | ||
| PCT/GB2003/000462 WO2003066056A1 (en) | 2002-02-05 | 2003-02-04 | Method of promoting neuronal growth |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003244452A1 true AU2003244452A1 (en) | 2003-09-02 |
Family
ID=27736189
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003244452A Abandoned AU2003244452A1 (en) | 2002-02-05 | 2003-02-04 | Method of promoting neuronal growth |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20070270432A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1471912A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2005522432A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2003244452A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003066056A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR039127A1 (es) | 2002-03-27 | 2005-02-09 | Glaxo Group Ltd | Compuesto de quinolina, procedimiento para su preparacion, composicion farmaceutica que lo comprende y uso del mismo para la fabricacion de un medicamento |
| JP4571507B2 (ja) | 2002-12-18 | 2010-10-27 | スベン ライフ サイエンシズ リミティド | セロトニン受容体親和性を有する四環系3−置換インドール |
| NZ544331A (en) | 2003-07-22 | 2010-03-26 | Arena Pharm Inc | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related thereto |
| ATE430752T1 (de) | 2004-01-02 | 2009-05-15 | Suven Life Sciences Ltd | Neue indenoä2,1-aüindene und isoindolä2,1-aüindol |
| US7713954B2 (en) | 2004-09-30 | 2010-05-11 | Roche Palo Alto Llc | Compositions and methods for treating cognitive disorders |
| US7998981B2 (en) | 2005-08-12 | 2011-08-16 | Suven Life Sciences Limited | Aminoaryl sulphonamide derivatives as functional 5-HT6 ligands |
| US7923566B2 (en) | 2005-08-16 | 2011-04-12 | Suven Life Sciences Limited | Alternative process for the preparation of losartan |
| CN101553467B (zh) | 2007-01-08 | 2011-12-07 | 苏文生命科学有限公司 | 5-(杂环基)烷基-n-(芳基磺酰基)吲哚化合物及其作为5-ht6配体的用途 |
| WO2008091863A1 (en) | 2007-01-23 | 2008-07-31 | Kalypsys, Inc. | Sulfonyl-substituted bicyclic compounds as ppar modulators for the treatment of non-alcoholic steatohepatitis |
| AU2008246947B2 (en) | 2007-05-03 | 2011-03-31 | Suven Life Sciences Limited | Aminoalkoxy aryl sulfonamide compounds and their use as 5-HT6 ligands |
| CA2703157C (en) | 2007-10-26 | 2013-02-05 | Suven Life Sciences Limited | Amino arylsulfonamide compounds and their use as 5-ht6 ligands |
| EP2254564A1 (en) | 2007-12-12 | 2010-12-01 | Glaxo Group Limited | Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline |
| WO2009123714A2 (en) | 2008-04-02 | 2009-10-08 | Arena Pharmaceuticals, Inc. | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
| US8318725B2 (en) | 2008-09-17 | 2012-11-27 | Suven Life Sciences Limited | Aryl indolyl sulfonamide compounds and their use as 5-HT6 ligands |
| MX2011002884A (es) | 2008-09-17 | 2011-04-21 | Suven Life Sciences Ltd | Compuestos de aril-sulfonamida-amina y su uso como ligandos de 5-ht6. |
| US9126946B2 (en) | 2008-10-28 | 2015-09-08 | Arena Pharmaceuticals, Inc. | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto |
| MX2012007783A (es) | 2010-01-05 | 2012-10-03 | Suven Life Sciences Ltd | Compuestos sulfona que actuan como ligandos del receptor 5-ht6. |
| KR101608499B1 (ko) | 2013-10-08 | 2016-04-01 | 이화여자대학교 산학협력단 | 4-니트로인돌 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 포함하는 5-ht6 수용체 관련 질환의 예방 또는 치료용 약학적 조성물 |
| JP2018516992A (ja) | 2015-06-12 | 2018-06-28 | アクソファント サイエンシーズ ゲーエムベーハーAxovant Sciences Gmbh | レム睡眠行動障害の予防および処置のために有用なジアリールおよびアリールヘテロアリール尿素誘導体 |
| CN108472285A (zh) | 2015-07-15 | 2018-08-31 | 阿速万科学有限责任公司 | 用于预防和治疗与神经退行性疾病相关联的幻觉的二芳基和芳基杂芳基脲衍生物 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DZ2376A1 (fr) * | 1996-12-19 | 2002-12-28 | Smithkline Beecham Plc | Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant. |
-
2003
- 2003-02-04 WO PCT/GB2003/000462 patent/WO2003066056A1/en not_active Ceased
- 2003-02-04 US US10/503,679 patent/US20070270432A1/en not_active Abandoned
- 2003-02-04 AU AU2003244452A patent/AU2003244452A1/en not_active Abandoned
- 2003-02-04 JP JP2003565480A patent/JP2005522432A/ja not_active Withdrawn
- 2003-02-04 EP EP03737355A patent/EP1471912A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP1471912A1 (en) | 2004-11-03 |
| US20070270432A1 (en) | 2007-11-22 |
| WO2003066056A1 (en) | 2003-08-14 |
| JP2005522432A (ja) | 2005-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003291352A1 (en) | Method of securing vertebrae | |
| AU2003239489A1 (en) | Method of treating dyslipidemic disorders | |
| AU2003282558A1 (en) | Nanopellets and method of making nanopellets | |
| AU2003280568A1 (en) | Method for clarifying soil | |
| AU2003277596A1 (en) | Method of deuterization | |
| AU2003258070A1 (en) | Electrodionization method | |
| AU2003276284A1 (en) | Method for inhibiting yeast growth | |
| AUPS096002A0 (en) | Method of construction | |
| AU2003234921A1 (en) | Method of knitting knit-wear | |
| AU2003221005A1 (en) | Method of wastewater treatment | |
| AU2003262911A1 (en) | Methods of promoting osteogenesis | |
| AU2002951913A0 (en) | Method of treatment | |
| AU2003226871A1 (en) | Pearl culture method | |
| AU2002100714A4 (en) | Method of hygiene | |
| AU2003278535A1 (en) | Histoscreen method | |
| AU2003222584A1 (en) | Method of producing organoacyloxysilanes | |
| AU2003246737A1 (en) | Antimicrobial coatings and method for production thereof | |
| AU2003233239A1 (en) | Method for the production of polymethylenepolysulfides | |
| AU2003296180A1 (en) | Method for purification of milbemycins | |
| AU2003290512A1 (en) | Method of weldbonding | |
| AU2003255785A1 (en) | Method of authentication | |
| AUPS230702A0 (en) | A method of treatment | |
| AU2002953042A0 (en) | Method of treatment | |
| AUPS079602A0 (en) | Method of treatment | |
| AUPS092502A0 (en) | Method of treatment-ii |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |